MedPath

Minimal invasive balloon expansion versus bypass operation to treat complicated occlusions and stenoses of the femoral and popliteal arteries

Not Applicable
Completed
Conditions
Atherosclerosis
Circulatory System
Peripheral arterial occlusive disease of the lower extremity
Registration Number
ISRCTN18315574
Lead Sponsor
Paracelsus Medical University (PMU)
Brief Summary

2019 Results article in https://pubmed.ncbi.nlm.nih.gov/31786218/ 2-year results (added 12/08/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35185122/ 4-year results (added 12/08/2022) 2023 Results article in https://doi.org/10.3390/jcm12103507 Long-Term Outcome of Bypass Surgery versus Endovascular Revascularization in Long Femoropopliteal Lesions (added 10/05/2024) 2022 Results article in https://doi.org/10.3390/medicina58091225 Long-Term Results of Endovascular Treatment with Nitinol Stents for Femoropopliteal TASC II C and D Lesions (added 10/05/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
218
Inclusion Criteria

1. Aged 30 years and over
2. Peripheral arterial occlusive disease of the lower extremity due to atherosclerosis
3. Disabling claudication (walking distance < 200 m) or critical ischemia (rest pain and/or tissue loss)
4. Radiologically verified long lesions (TASC II Type C or D) of the femoral and/or politeal artery
5. Symptoms for more than 2 months
6. Unimpaired ipsilateral iliac arteries
7. Capacity to provide informed consent

Exclusion Criteria

1. Acute ischemia
2. Embolic occlusion of the femoropopliteal segment
3. Trauma
4. Non-disabling claudication (walking distance > 200 m)
5. Radiologically verified short femoropopliteal lesions (TASC II Type A and B)
6. Vasculitis
7. Renal insufficiency (glomerular filtration rate < 45 ml/min/1.73 m2)
8. No informed consent
9. Pregnancy
10. Patient too frail for bypass surgery: American Society of Anesthesiologists (ASA) - Class >3

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath